Zimmer Biomet receives FDA 510(k) clearance for shoulder replacement system
Click Here to Manage Email Alerts
Zimmer Biomet Inc. has announced FDA 510(k) clearance of the Identity shoulder system for anatomic, reverse and revision shoulder replacement procedures, according to a company press release.
The Identity shoulder system is compatible with a range of humeral and glenoid options to fit each patient’s unique anatomy, according to the release.
“The FDA clearance of the Identity shoulder system is exciting because it offers surgeons a highly adaptable solution for anatomic, reverse and revision procedures to help patients optimize natural shoulder movement,” Ivan Tornos, chief operating officer at Zimmer Biomet, said in the release. “This significant milestone adds to progress in our growing sports medicine, extremities and trauma portfolio, a critical area of focus as we expand our position as a global leader in innovative medical technologies that maximize mobility,” Tornos added.